Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Reduced fractures with denosumab in postmenopausal women and men with prostate cancer

Sep. 9, 2009

Conjugates of HMG-CoA reductase and renin inhibitors in development at LEK

Sep. 8, 2009

Ingested hrIFN-alpha preserves beta-cell function in diabetic children

Sep. 8, 2009

Dilafor reports phase II tafoxiparin results in preventing protracted labor

Sep. 7, 2009

Takeda receives FDA complete response letter for fixed-dose Actos and alogliptin benzoate

Sep. 7, 2009

Sanwa describes thyroid hormone receptor ligands for the treatment of hyperlipidemia

Sep. 7, 2009

Diamyd Medical reports 4-year follow-up data from phase II study of Diamyd

Sep. 4, 2009

Pharming submits new MAA to EMEA for Rhucin for acute hereditary angioedema attacks

Sep. 4, 2009

FDA extends review period for Endo's testosterone undecanoate for hypogonadism

Sep. 4, 2009

New naturally derived antidiabetic compound preserves beta-cell function in preclinical studies

Sep. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...